Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Local Effects of Epinephrine on Lactate, Glucose, Lipid and Protein Metabolism in Bilaterally Perfused Human Legs

This study has been completed.
Information provided by (Responsible Party):
University of Aarhus Identifier:
First received: April 9, 2010
Last updated: November 4, 2011
Last verified: November 2011
The purpose of this study is to define the local metabolic effects of epinephrine in the bilaterally perfused human leg.

Condition Intervention
Drug: Epinephrine

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single Blind (Subject)
Primary Purpose: Basic Science
Official Title: Local Effects of Epinephrine on Lactate, Glucose, Lipid and Protein Metabolism in Bilaterally Perfused Human Legs

Resource links provided by NLM:

Further study details as provided by University of Aarhus:

Primary Outcome Measures:
  • Arterio-Venous balances of metabolites [ Time Frame: 6 hours infusion ] [ Designated as safety issue: No ]
    Acute regional effect of epinephrine infusion in the femoral artery

Enrollment: 10
Study Start Date: October 2004
Study Completion Date: January 2010
Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)
Intervention Details:
    Drug: Epinephrine
    unilateral leg infusion of Epinephrine 0.4 micrograms/m2/min
    Other Name: Adrenaline

Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Male

Exclusion Criteria:

  • Comorbidity
  • Females
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01116609

Medical research laboratories, Aarhus University Hospital
Aarhus, Denmark, 8000
Sponsors and Collaborators
University of Aarhus
Principal Investigator: Niels Moller, Professor Medical Research Laboratories, Aarhus University, Denmark
  More Information

Responsible Party: University of Aarhus Identifier: NCT01116609     History of Changes
Other Study ID Numbers: Epi-perfusion 
Study First Received: April 9, 2010
Last Updated: November 4, 2011
Health Authority: Denmark: The Regional Committee on Biomedical Research Ethics

Keywords provided by University of Aarhus:
Effects of epinephrine in healthy volunteers

Additional relevant MeSH terms:
Epinephryl borate
Adrenergic alpha-Agonists
Adrenergic Agonists
Adrenergic Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Physiological Effects of Drugs
Adrenergic beta-Agonists
Bronchodilator Agents
Autonomic Agents
Peripheral Nervous System Agents
Anti-Asthmatic Agents
Respiratory System Agents
Vasoconstrictor Agents processed this record on October 21, 2016